COVID-19 IgG/IgM Rapid Test

COVID 19 (SARS-CoV-2) IgG/IgM Rapid Lateral Flow Test (colloidal gold based)

OEM only


    - Uncut Sheets


IgM/IgG Rapid Kit can specifically detect IgM and IgG antibodies of COVID-19, covering the entire course of infection and recovery period of patients. This approach improves the overall diagnosis of COVID-19 in both acute and recovery phases of illness.

This kit utilizes the principle of colloidal gold immunochromatography to qualitatively detect the new coronavirus (COVID-19) IgG / IgM antibodies in human serum and plasma. Lateral flow immunochromatographic assay provides an easy workflow, short turnaround time, and rapid diagnosis of COVID-19 suspected patients.

This method does not require expensive medical instruments and consumables. Just take the specimen and add it to the sample well, and then add the required amount of a diluent. The resultat will be availible within 20 min. 

Accuracy:80% ~ 90%

Specificity: 97%

Download the protocol: COVID-19 IgG IgM (SARS-CoV-2) Rapid Lateral Flow Test (colloidal gold-based)

AIVD’s POCT has been tested by the Chinese CDC; commonly utilized in Wuhan recovery centers and isolated areas, hospitals all over China.



Result Judgment



If there are clinical symptoms, such as fever, cough, and lung lesions on CT, then it can be determined as a suspected patient. Recommended test the patient using COVID-19 IgG/IgM test cassette or PCR-based method within the next 7 days one more time.



If the CT shows a presence of a lung disease, the patient could be considered as a COVID-19 infected patient in the early stage of infection



Confirmed patient



Confirmed patients. If there are no clinical symptoms, could be patients, who are getting a medical treatment at the moment or already got a treatment course and need to be observed in following several days, if IgM does not appear positive, and no clinical symptoms reappear, the patient can be determined as a recovered patient.